German cabinet approves legislation to ban glyphosate from 2024



BERLIN, Feb 10 (Reuters) - Farmers in Germany will have to gradually reduce their use of glyphosate and stop using it completely from 2024 in order to preserve clean habitats for insects, under draft legislation passed by the country's cabinet on Wednesday.

"The exit from glyphosate is coming. Conservationists have been working toward this for a long time. Glyphosate kills everything that is green and takes away insects' basis for life," environment minister Svenja Schulze said in a statement.

Farmers have criticised the planned law, saying it puts the livelihoods of family-run farms at risk and that bans would be less effective in fostering biodiversity than cooperation between farmers and conservationists.

Glyphosate, first developed by Bayer's BAYGn.DE Monsanto under the Roundup brand, has generated intense global debate over its safety since a World Health Organization agency concluded in 2015 that it probably causes cancer.

While regulators worldwide have determined glyphosate to be safe, Bayer agreed in June to settle nearly 100,000 U.S. lawsuits for $10.9 billion, denying claims that Roundup caused cancer.

Under the draft German legislation, the use of herbicides and insecticides that could harm bees will be banned from certain areas. In addition, new installations of certain types of lights will be forbidden to reduce light pollution.

Joachim Rukwied, head of the German farmers' association, said the proposed legislation was the wrong way to achieve more environmental protection, adding: "A partnership between agriculture and conservation, with joint goals, measures and incentives, would be more promising."

The law needs to be passed by both the Bundestag lower house and the Bundesrat upper house which represents the interests of the 16 regional governments in Germany, a process that typically takes several months.
Reporting by Maria Sheahan; Editing by Pravin Char

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

We are using cookies to give you the best experience on our website. Read more or change your cookie settings.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.